The company’s request to the Food and Drug Administration is substantially broader than what Pfizer and BioNTech sought earlier in the week.
View original article
Contributor: Katie Shepherd
The company’s request to the Food and Drug Administration is substantially broader than what Pfizer and BioNTech sought earlier in the week.
View original article
Contributor: Katie Shepherd